Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations

Jonathan H. Chung, Jinlu Cai, Barrie G. Suskin, Zhengdong Zhang, Karlene Coleman, Bernice E. Morrow

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The 22q11.2 deletion syndrome (22q11DS) affects 1:4,000 live births and presents with highly variable phenotype expressivity. In this study, we developed an analytical approach utilizing whole-genome sequencing (WGS) and integrative analysis to discover genetic modifiers. Our pipeline combined available tools in order to prioritize rare, predicted deleterious, coding and noncoding single-nucleotide variants (SNVs), and insertion/deletions from WGS. We sequenced two unrelated probands with 22q11DS, with contrasting clinical findings, and their unaffected parents. Proband P1 had cognitive impairment, psychotic episodes, anxiety, and tetralogy of Fallot (TOF), whereas proband P2 had juvenile rheumatoid arthritis but no other major clinical findings. In P1, we identified common variants in COMT and PRODH on 22q11.2 as well as rare potentially deleterious DNA variants in other behavioral/neurocognitive genes. We also identified a de novo SNV in ADNP2 (NM_014913.3:c.2243G>C), encoding a neuroprotective protein that may be involved in behavioral disorders. In P2, we identified a novel nonsynonymous SNV in ZFPM2 (NM_012082.3:c.1576C>T), a known causative gene for TOF, which may act as a protective variant downstream of TBX1, haploinsufficiency of which is responsible for congenital heart disease in individuals with 22q11DS. Circos plot showing coding (red) and noncoding (green) genetic variants and their affected genes in an individual with 22q11.2 deletion syndrome. Whole genome sequencing and integrative analysis were used to prioritize genetic variants and identify a small subset of genes (blue labels) that may influence the phenotypes seen in this individual.

Original languageEnglish (US)
Pages (from-to)797-807
Number of pages11
JournalHuman Mutation
Volume36
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

DiGeorge Syndrome
Genetic Association Studies
Genome
Tetralogy of Fallot
Nucleotides
Genes
Phenotype
Haploinsufficiency
Juvenile Arthritis
Live Birth
Heart Diseases
Anxiety
DNA
Proteins

Keywords

  • 22q11.2 deletion syndrome
  • Integrative analysis
  • Juvenile rheumatoid arthritis
  • Schizophrenia psychosis
  • Tetralogy of Fallot

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations. / Chung, Jonathan H.; Cai, Jinlu; Suskin, Barrie G.; Zhang, Zhengdong; Coleman, Karlene; Morrow, Bernice E.

In: Human Mutation, Vol. 36, No. 8, 01.08.2015, p. 797-807.

Research output: Contribution to journalArticle

@article{6611017cc24e455eacd33445543a575b,
title = "Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations",
abstract = "The 22q11.2 deletion syndrome (22q11DS) affects 1:4,000 live births and presents with highly variable phenotype expressivity. In this study, we developed an analytical approach utilizing whole-genome sequencing (WGS) and integrative analysis to discover genetic modifiers. Our pipeline combined available tools in order to prioritize rare, predicted deleterious, coding and noncoding single-nucleotide variants (SNVs), and insertion/deletions from WGS. We sequenced two unrelated probands with 22q11DS, with contrasting clinical findings, and their unaffected parents. Proband P1 had cognitive impairment, psychotic episodes, anxiety, and tetralogy of Fallot (TOF), whereas proband P2 had juvenile rheumatoid arthritis but no other major clinical findings. In P1, we identified common variants in COMT and PRODH on 22q11.2 as well as rare potentially deleterious DNA variants in other behavioral/neurocognitive genes. We also identified a de novo SNV in ADNP2 (NM_014913.3:c.2243G>C), encoding a neuroprotective protein that may be involved in behavioral disorders. In P2, we identified a novel nonsynonymous SNV in ZFPM2 (NM_012082.3:c.1576C>T), a known causative gene for TOF, which may act as a protective variant downstream of TBX1, haploinsufficiency of which is responsible for congenital heart disease in individuals with 22q11DS. Circos plot showing coding (red) and noncoding (green) genetic variants and their affected genes in an individual with 22q11.2 deletion syndrome. Whole genome sequencing and integrative analysis were used to prioritize genetic variants and identify a small subset of genes (blue labels) that may influence the phenotypes seen in this individual.",
keywords = "22q11.2 deletion syndrome, Integrative analysis, Juvenile rheumatoid arthritis, Schizophrenia psychosis, Tetralogy of Fallot",
author = "Chung, {Jonathan H.} and Jinlu Cai and Suskin, {Barrie G.} and Zhengdong Zhang and Karlene Coleman and Morrow, {Bernice E.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1002/humu.22814",
language = "English (US)",
volume = "36",
pages = "797--807",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations

AU - Chung, Jonathan H.

AU - Cai, Jinlu

AU - Suskin, Barrie G.

AU - Zhang, Zhengdong

AU - Coleman, Karlene

AU - Morrow, Bernice E.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The 22q11.2 deletion syndrome (22q11DS) affects 1:4,000 live births and presents with highly variable phenotype expressivity. In this study, we developed an analytical approach utilizing whole-genome sequencing (WGS) and integrative analysis to discover genetic modifiers. Our pipeline combined available tools in order to prioritize rare, predicted deleterious, coding and noncoding single-nucleotide variants (SNVs), and insertion/deletions from WGS. We sequenced two unrelated probands with 22q11DS, with contrasting clinical findings, and their unaffected parents. Proband P1 had cognitive impairment, psychotic episodes, anxiety, and tetralogy of Fallot (TOF), whereas proband P2 had juvenile rheumatoid arthritis but no other major clinical findings. In P1, we identified common variants in COMT and PRODH on 22q11.2 as well as rare potentially deleterious DNA variants in other behavioral/neurocognitive genes. We also identified a de novo SNV in ADNP2 (NM_014913.3:c.2243G>C), encoding a neuroprotective protein that may be involved in behavioral disorders. In P2, we identified a novel nonsynonymous SNV in ZFPM2 (NM_012082.3:c.1576C>T), a known causative gene for TOF, which may act as a protective variant downstream of TBX1, haploinsufficiency of which is responsible for congenital heart disease in individuals with 22q11DS. Circos plot showing coding (red) and noncoding (green) genetic variants and their affected genes in an individual with 22q11.2 deletion syndrome. Whole genome sequencing and integrative analysis were used to prioritize genetic variants and identify a small subset of genes (blue labels) that may influence the phenotypes seen in this individual.

AB - The 22q11.2 deletion syndrome (22q11DS) affects 1:4,000 live births and presents with highly variable phenotype expressivity. In this study, we developed an analytical approach utilizing whole-genome sequencing (WGS) and integrative analysis to discover genetic modifiers. Our pipeline combined available tools in order to prioritize rare, predicted deleterious, coding and noncoding single-nucleotide variants (SNVs), and insertion/deletions from WGS. We sequenced two unrelated probands with 22q11DS, with contrasting clinical findings, and their unaffected parents. Proband P1 had cognitive impairment, psychotic episodes, anxiety, and tetralogy of Fallot (TOF), whereas proband P2 had juvenile rheumatoid arthritis but no other major clinical findings. In P1, we identified common variants in COMT and PRODH on 22q11.2 as well as rare potentially deleterious DNA variants in other behavioral/neurocognitive genes. We also identified a de novo SNV in ADNP2 (NM_014913.3:c.2243G>C), encoding a neuroprotective protein that may be involved in behavioral disorders. In P2, we identified a novel nonsynonymous SNV in ZFPM2 (NM_012082.3:c.1576C>T), a known causative gene for TOF, which may act as a protective variant downstream of TBX1, haploinsufficiency of which is responsible for congenital heart disease in individuals with 22q11DS. Circos plot showing coding (red) and noncoding (green) genetic variants and their affected genes in an individual with 22q11.2 deletion syndrome. Whole genome sequencing and integrative analysis were used to prioritize genetic variants and identify a small subset of genes (blue labels) that may influence the phenotypes seen in this individual.

KW - 22q11.2 deletion syndrome

KW - Integrative analysis

KW - Juvenile rheumatoid arthritis

KW - Schizophrenia psychosis

KW - Tetralogy of Fallot

UR - http://www.scopus.com/inward/record.url?scp=84937727974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937727974&partnerID=8YFLogxK

U2 - 10.1002/humu.22814

DO - 10.1002/humu.22814

M3 - Article

VL - 36

SP - 797

EP - 807

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 8

ER -